HighTower Advisors, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 178 filers reported holding HAEMONETICS CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$351,000
-38.7%
3,920
-18.9%
0.00%
-50.0%
Q4 2020$573,000
+91.6%
4,836
-43.3%
0.00%
+100.0%
Q1 2016$299,000
+3.1%
8,528
-5.8%
0.00%
-66.7%
Q4 2015$290,0009,0560.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2016
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders